NextGen liquiCORE 52 gene panel
NextGen Liquicore 52 Gene Panel by NGS, Peripheral Blood ** Price
Brief Details
What Is a NextGen LiquiCore 52 Gene Panel?
The NextGen LiquiCore 52 Gene Panel is an advanced liquid biopsy test that uses Next-Generation Sequencing (NGS) technology to analyse your blood for genetic changes in cancer cells. This test examines tiny fragments of DNA released by cancer cells into your bloodstream, providing valuable insights into your tumour without the need for a surgical biopsy. It helps doctors understand the genetic makeup of your cancer and guide personalised treatment decisions.
What Does the NextGen LiquiCore 52 Gene Panel Measure?
This liquid biopsy test provides comprehensive genetic information by measuring several key elements:
- Circulating tumour DNA (ctDNA): DNA fragments shed by cancer cells into your bloodstream.
• Single-nucleotide variants (SNVs) and short insertions/deletions: Small genetic changes in cancer-related genes.
• Gene fusions: Abnormal joining of two separate genes that can drive cancer growth.
• Copy number variations (CNVs): Changes in the number of copies of specific genes.
• Tumour suppressor gene alterations: Changes in genes that normally prevent cancer development.
• MET exon 14 skipping: Detects specific changes in the MET gene associated with certain cancers.
NextGen LiquiCore 52 Gene Panel: Who Needs It and Why It's Done
Who Should Get a NextGen LiquiCore 52 Gene Panel?
This NGS sequencing test is beneficial for specific groups of patients:
- Patients with a confirmed cancer diagnosis: To identify the best targeted therapy options.
• Patients where tissue biopsy is difficult: When tumours are in hard-to-reach locations or patients are too frail for surgery.
• Patients undergoing cancer treatment: To monitor treatment effectiveness and track disease progression.
• Patients in remission: To detect early signs of minimal residual disease?or cancer recurrence before it is visible on scans.
• Patients with solid tumours: Particularly those with health conditions such as lung, breast, colorectal, prostate, or other common cancers.
Why Is a NextGen LiquiCore 52 Gene Panel Done?
This test enables personalised cancer treatment by providing a comprehensive genetic profile of your tumour, helping doctors select the most effective targeted therapies based on your cancer's unique genetic characteristics.
Importance of a NextGen LiquiCore 52 Gene Panel
The NextGen LiquiCore 52 Gene Panel plays a crucial role in modern cancer care by offering several significant advantages. This non-invasive liquid biopsy eliminates the need for surgical tissue biopsies, reducing patient discomfort and recovery time. The test enables precise oncology treatment by identifying specific genetic mutations that can be targeted with personalised therapies, often leading to better treatment outcomes with fewer side effects.
Unlike single tissue samples, this comprehensive test captures DNA from all parts of the tumour, providing a complete genetic picture. The test also allows dynamic monitoring of cancer evolution and treatment resistance, enabling doctors to adjust treatment strategies as needed for optimal patient care.
NextGen LiquiCore 52 Gene Panel Booking & Reports – Metropolis Healthcare India
How to Book a NextGen LiquiCore 52 Gene Panel?
- Simple Online Booking
Booking can be done through the Metropolis Healthcare App or website. Select the 'NextGen LiquiCore 52 Gene Panel', choose a convenient time slot, and provide your address for a blood test at home. You can also visit the nearest Metropolis Lab if you prefer to give the sample directly at the lab.
- Safe Home Sample Collection
Our trained phlebotomists ensure the timely collection of your sample while strictly following all safety and hygiene protocols.
- Sample Tracking Updates
Stay informed at every step. From collection to testing, you can track your sample directly through the Metropolis Healthcare website.
- Accurate Laboratory Testing
Your sample is processed at our NABL & CAP accredited laboratories, where expert technicians ensure accurate results.
- Quick & Easy Reports
Receive your test reports promptly via email, WhatsApp, or by downloading them directly from the Metropolis Healthcare website or app.
Is Home Sample Collection for the NextGen LiquiCore 52 Gene Panel Available Near You?
Yes, Metropolis Healthcare provides home blood sample collection for the NextGen LiquiCore 52 Gene Panel. Our trained phlebotomists will visit your location at your preferred time, ensuring safe and hygienic sample collection using proper protocols. This service ensures you receive the same accurate, reliable results from our NABL & CAP accredited laboratories without the need to visit a pathology lab.
How Long Does It Take to Get a NextGen LiquiCore 52 Gene Panel Report?
Reports are usually available within 20 days once the sample reaches the lab.
Note: Reporting time may vary depending on your location.
Where Can I See or Get NextGen LiquiCore 52 Gene Panel Results?
Test results from Metropolis Healthcare can be accessed through multiple convenient channels. You can log in to the Metropolis website using your credentials or use the Metropolis Healthcare App to view and download your reports. Additionally, test reports are sent via email or WhatsApp, and you also have the option to collect a physical copy directly from the lab.
Interpreting NextGen LiquiCore 52 Gene Panel Results
What Your NextGen LiquiCore 52 Gene Panel Results May Indicate
Your test results will show whether genetic mutations were found in the 52 genes analysed, helping guide your treatment decisions:
|
Parameters |
Detected |
Not Detected |
|
DNA Mutations |
Specific genetic changes have been found that may guide targeted therapy selection. |
No cancer-related genetic mutations identified in the analysed genes |
|
RNA Fusions |
Abnormal gene combinations have been found that may respond to specific treatments. |
No cancer-related gene fusions identified |
Conditions that May Affect NextGen LiquiCore 52 Gene Panel Accuracy
Several factors can influence your NextGen LiquiCore 52 Gene Panel results and should be discussed with your healthcare team:
- Sample quality: Haemolysed, lipemic, icteric, or clotted blood samples may affect results.
• Insufficient sample volume: Less than the required 9 ml of blood may lead to inconclusive results.
• Tumour characteristics: Not all cancers shed detectable DNA into the bloodstream.
• Low tumour burden: Very small tumours may not release enough DNA for detection.
• Recent treatments: Chemotherapy or radiation may temporarily reduce circulating tumour DNA.
• Timing of collection: Results may vary depending on disease stage and progression.
• Storage conditions: Improper sample handling or temperature conditions can affect DNA integrity.
• Medication effects: Certain cancer treatments may reduce circulating tumour DNA levels, affecting detection sensitivity.
How Is a NextGen LiquiCore 52 Gene Panel Done?
The test process involves several steps to ensure accurate results:
- A healthcare professional cleans the area on your arm with an antiseptic.
- An elastic band is tied around your upper arm to make the veins more visible.
- A needle is inserted into a vein to collect 9 ml of blood in a special Streck tube.
- The needle is removed, and a bandage is applied to the puncture site.
- Your blood sample is labelled and sent to the pathology lab for processing.
How Should You Prepare for a NextGen LiquiCore 52 Gene Panel?
Preparing for this test is straightforward and requires minimal special preparation:
- No fasting required: You can eat and drink normally before the test.
• Continue medications: Take your regular medications unless specifically instructed otherwise by your doctor.
• Bring required documents: Ensure you have your medical prescription and histopathology report.
• Provide clinical history: Be prepared to share details about your cancer diagnosis and treatment history.
• Wear comfortable clothing: Choose clothing that allows easy access to your arm for blood collection.
Diseases that a NextGen LiquiCore 52 Gene Panel Can Help Detect
The NextGen LiquiCore 52 Gene Panel is designed to detect genetic alterations associated with various solid tumours:
- Lung cancer: Including non-small cell and small cell lung cancers
• Breast cancer: Various subtypes, including hormone receptor-positive and HER2-positive
• Colorectal cancer: Colon and rectal cancers with different genetic profiles
• Gastric cancer: Stomach cancers with actionable mutations
Packages that You Can Book With Metropolis Healthcare
Metropolis Healthcare offers comprehensive cancer testing options to support your diagnostic and treatment needs:
|
Test/Package Name |
Purpose/Highlights |
|
Measures the total number of mutations in cancer cells to predict immunotherapy response. |
|
|
Tumour/Cancer Marker Profile Test |
Comprehensive screening for multiple cancer markers in blood. |
|
Extensive genetic analysis of tissue samples for personalised cancer treatment. |
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.